8-K ·Filed Apr 28, 2026
8-K context-dependent: Items 8.01
Actionable Insight • Neutral
The patent allowance strengthens BioCardia's IP portfolio but does not change near-term fundamentals. Monitor upcoming FDA and PMDA meetings in May 2026 for potential catalysts.
Final — all horizons settled through T+60d
BCDA ▼ -20.61% at T+60d
NEUTRAL call -20.61% · α vs SPY -24.60% · entry $1.14 → $0.9050
T+1d
-3.51%
call -3.51% · α -3.50%
$1.10
settled 6mo ago
T+5d
-0.88%
call -0.88% · α -2.57%
$1.13
settled 6mo ago
T+20d
-20.18%
call -20.18% · α -25.64%
$0.9100
settled 5mo ago
T+60d
-20.61%
call -20.61% · α -24.60%
$0.9050
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
BioCardia announced the allowance of a Japanese patent for its Heart3D Fusion Imaging software, which supports its CardiAMP cell therapy procedures. This is a routine intellectual property development with no immediate financial impact.
Key Facts
- Japanese patent allowed for Heart3D Fusion Imaging software
- Patent covers target site selection, entry, and update with automatic remote image annotation
- Technology intended for treatment planning and real-time navigation during CardiAMP Cell Therapy procedures
Financial Impact
No financial impact disclosed
Risk Factors
- No guarantee of commercialization or revenue from the patent
- Company's liquidity position and ability to raise additional funds as noted in forward-looking statements
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-013535 |
| Exhibit: ex_951934.htm | 0001437749-26-013535 |
| Document: 0001437749-26-013535-index-headers.html | 0001437749-26-013535 |
| Document: 0001437749-26-013535-index.html | 0001437749-26-013535 |
| Document: 0001437749-26-013535.txt | 0001437749-26-013535 |
27 reports for BCDA
60% Hit rate @ T+1 Went positive at some point 12 of 15 best @ T+20▲ +30.43%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.8975 $1.04 | ▲ +15.88% | ▲ +15.54% | $0.9000 (+0.28%) |
Oct 19, 2026 7d ago | Press Release | $0.9000 $1.04 | ▲ +15.56% | ▲ +15.22% | $0.9000 (−0.00%) |
Oct 7, 2026 19d ago | 8-K | $1.09 $1.06 | ▼ −2.75% | ▼ −2.33% | $0.9000 (−17.43%) |
Oct 1, 2026 25d ago | 8-K | $1.02 $1.04 | ▲ +1.96% | ▲ +1.22% | $0.9000 (−11.76%) |
Oct 1, 2026 25d ago | Press Release | $1.02 $1.04 | ▲ +1.96% | ▲ +1.22% | $0.9000 (−11.76%) |
Sep 23, 2026 4w ago | 8-K | $1.05 $1.07 | ▲ +1.90% | ▲ +1.99% | $0.9000 (−14.29%) |
Sep 23, 2026 4w ago | Press Release | $1.05 $1.07 | ▲ +1.90% | ▲ +1.99% | $0.9000 (−14.29%) |
Sep 10, 2026 6w ago | 8-K | $1.10 $1.08 | ▼ −1.82% | ▼ −2.67% | $0.9000 (−18.18%) |
Aug 24, 2026 9w ago | 8-K | $1.06 $1.13 | ▲ +6.60% | ▲ +6.28% | $0.9000 (−15.09%) |
Aug 5, 2026 11w ago | Press Release | $0.9500 $0.9496 | ▼ −0.04% | ▲ +0.12% | $0.9000 (−5.26%) |
Showing 10 of 27
US Market Status
Market Closed — Opens in 7h 27m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers